Validated pretreatment prediction models for response to neoadjuvant therapy in patients with rectal cancer: a systematic review and critical appraisal

MD Tanaka, BM Geubels, BA Grotenhuis… - Cancers, 2023 - mdpi.com
Simple Summary Organ preservation strategies can be offered to patients with rectal cancer
that show a strong response to preoperative treatment in order to avoid major surgery …

Delta-radiomics signature predicts treatment outcomes after preoperative chemoradiotherapy and surgery in rectal cancer

SH Jeon, C Song, EK Chie, B Kim, YH Kim, W Chang… - Radiation …, 2019 - Springer
Background To develop and compare delta-radiomics signatures from 2-(2D) and 3-
dimensional (3D) features that predict treatment outcomes following preoperative …

Adjuvant chemotherapy in rectal cancer patients who achieved a pathological complete response after preoperative chemoradiotherapy: a systematic review and …

YJ Lim, Y Kim, M Kong - Scientific reports, 2019 - nature.com
This study evaluated the prognostic impact of ACT in patients who achieved a pathological
complete response (pCR). Articles published from January 1990 to September 2018 were …

Gut microbiome composition is associated with a pathologic response after preoperative chemoradiation in patients with rectal cancer

BS Jang, JH Chang, EK Chie, K Kim, JW Park… - International Journal of …, 2020 - Elsevier
Purpose There are ongoing investigations to find promising biomarkers for predicting a
complete response (CR) after concurrent chemoradiation (CCRT) in rectal cancer. We …

Multiparametric MRI and whole slide image-based pretreatment prediction of pathological response to neoadjuvant chemoradiotherapy in rectal cancer: a multicenter …

L Shao, Z Liu, L Feng, X Lou, Z Li, XY Zhang… - Annals of surgical …, 2020 - Springer
Background The aim of this work is to combine radiological and pathological information of
tumor to develop a signature for pretreatment prediction of discrepancies of pathological …

[HTML][HTML] Predicting treatment response to neoadjuvant chemoradiotherapy in local advanced rectal cancer by biopsy digital pathology image features

F Zhang, S Yao, Z Li, C Liang, K Zhao… - Clinical and …, 2020 - ncbi.nlm.nih.gov
Quantitative features extracted from biopsy digital pathology images can provide predictive
information for neoadjuvant chemoradiotherapy (nCRT) in local advanced rectal cancer …

Impact of a ketogenic diet intervention during radiotherapy on body composition: IV. Final results of the KETOCOMP study for rectal cancer patients

RJ Klement, PS Koebrunner, D Meyer, S Kanzler… - Clinical Nutrition, 2021 - Elsevier
Background & aims Obesity and low muscle mass are associated with worse outcomes of
colorectal cancer patients. We conducted a controlled trial to study the impact of a ketogenic …

Survival landscape of different tumor regression grades and pathologic complete response in rectal cancer after neoadjuvant therapy based on reconstructed …

J Li, X Huang, P Gao, Y Song, X Chen, X Lv, Y Fu… - BMC cancer, 2021 - Springer
Background Neoadjuvant therapy can lead to different tumor regression grades (TRG) in
rectal cancer after neoadjuvant therapy. The purposes of this study are to investigate the …

Immunogenic cell death by the novel topoisomerase I inhibitor TLC388 enhances the therapeutic efficacy of radiotherapy

KCY Huang, SF Chiang, PC Yang, TW Ke, TW Chen… - Cancers, 2021 - mdpi.com
Simple Summary This study aims to evaluate the induction of immunogenic cell death (ICD)
for anticancer immunity by the novel topoisomerase I inhibitor lipotecan. These results show …

An MRI-based scoring system for pretreatment risk stratification in locally advanced rectal cancer

M Zhao, L Feng, K Zhao, Y Cui, Z Li, C Ke… - British Journal of …, 2023 - nature.com
Background Accurately assessing the risk of recurrence in patients with locally advanced
rectal cancer (LARC) before treatment is important for the development of treatment …